DILIGENCE COVER SHEET
Open evidence snapshot →Start with the evidence currently retained.
One glance at identity, filing chronology and source layers before opening the full issuer dossier.
SEC-OBSERVED OTC ISSUER · CIK 0001938569
Palomino Laboratories Inc.
Follow saves this issuer to your watchlist. Get alerts creates in-site notices only for official events first observed after you enable alerts.
Public-record entry point
This issuer is currently present in the SEC company ticker-and-exchange reference file with exchange field OTC. Retained filing nodes, when available, are shown below; the SEC issuer record remains controlling and older history may be incomplete.
Generate automated SEC filing briefISSUER CHANGE LEDGER
Newly detected public-record events
Events first captured by this monitoring workflow for this CIK. Open the source and the filing brief before making any legal, diligence or transaction conclusion.
- 8-K/APalomino Laboratories Inc.Official source →
- DEF 14APalomino Laboratories Inc.Official source →
- PRE 14APalomino Laboratories Inc.Official source →
FILING SEQUENCE CONTEXT
What changed in the filing path
Relationship cues are generated from the order and form type of retained official filings. They are not a clause-by-clause document redline; verify terms in the linked source.
Latest registrationNo registration form retained
Latest amendment8-K/A · 2026-10-14
EffectivenessNo EFFECT retained
- Reporting & disclosure8-K/A
Amendment form captured; no prior same-lane filing is retained in this timeline
Open official filing → - Ownership & governancePRE 14A
No earlier same-lane record retained in this timeline
Open official filing →
Next diligence steps
- Open the SEC company record and identify the controlling filing sequence.
- Capture registration, amendment, prospectus and official market-action records.
- Use the resulting evidence chain with independently retained legal, accounting and execution professionals.
Source: SEC company ticker-and-exchange reference data, last observed 2026-10-21 23:15 UTC. This entry is not a shell-company determination, active-trading determination or safety assessment.
INSTANT PUBLIC-RECORD FILE
Generate for this issuer · US$79 →Need a dated issuer evidence chain?
Generate a source-linked Shell Readiness File for first-pass internal screening. It organizes public records; it does not determine shell status or transaction feasibility.
ISSUER IDENTITY & SOURCE LINEAGE
37 retained public-record nodesOfficial reference points for this company.
SEC CIK0001938569
Current OTC reference$PALX · observed 2026-10-21
Earliest retained official filing10-Q · 2023-11-14
First monitor captureNot retained
This page distinguishes the earliest retained official filing from an issuer’s first public trading or initial quotation date. Missing history is not a conclusion about the issuer.
EXTERNAL PUBLIC-RECORD CHECKS
Verify beyond this monitor.
These links open third-party official sources. They do not imply a match, a current quotation, a legal finding, or an OTC Markets data license.
COVERAGE STATUS
Request ticker review →What this dossier currently contains.
Issuer identityCurrent SEC OTC reference retainedLast directory observation: 2026-10-21
SEC record layer37 retained filing nodesLast stored capture: 2026-10-21 21:40
FINRA action layer0 matched actionsMatched by current ticker PALX · last stored: Not retained
“Not retained” means this monitor does not currently hold a matching record in the named source layer. It does not establish absence, quotation status, compliance status, or issuer quality.
SEC FILING COMPLETENESS
Retained SEC record, including historical submissions.
Recent filings are retained from the SEC submissions index. On dossier visits, the monitor also checks the SEC’s older submission archive in the background. This is a filing-history view—not a quotation, trading, financing-close or capitalization record.
Historical archive check pending retry. 2026-10-22 16:28 UTC. “Not retained” or a low count means this monitor has not stored a matching filing; it does not establish absence of a filing or issuer activity.
SEC LITIGATION RELEASE CHECK
SEC Litigation Releases →Official release-title candidates, not a risk label.
The SEC describes Litigation Releases as records concerning civil actions brought by the Commission in federal court. This monitor checks only the SEC’s official release feed and only surfaces a strict company-name title candidate for human review.
No exact normalized company-name candidate in the retained SEC Litigation Releases cache. Feed cache: 2026-10-22 17:34 UTC.
A candidate does not confirm that this issuer is a respondent, defendant, affiliate, currently subject to an action, or associated with a filing. Names can overlap or change. Open the official SEC source and independently verify legal identity, entity status and context.
Identity scope: SEC former submission names are retained on this dossier and may be used only as additional manual review prompts. The automated candidate list above remains limited to the current name to reduce false matches.
SEC NAME HISTORY
Names retained under this CIK.
These names come from the SEC submissions record and are useful identity clues when reviewing older filings or release titles. They do not independently prove a merger, reverse merger, ticker change, transaction date or continuity of business.
- Palomino Laboratories Inc.Current SEC submission name
- Unite Acquisition 3 Corp.Former SEC submission name · 2023-08-10T04:00:00. to 2025-08-29T04:00:00.
SEC STRUCTURED FINANCIAL FACTS
SEC Companyfacts JSON →Latest retained dollar facts, with period context.
Values come directly from SEC Companyfacts. Different facts can have different reporting periods or filing dates, so they are not combined into ratios or performance conclusions.
Source check: 2026-10-22 16:28 UTC. “Not retained” means no compatible USD fact was stored by this monitor; it does not establish that the company has no revenue, cash, assets, filings, operations or reporting obligation. Open the SEC filing for full context.
RESEARCH NOTES
Source-bound professional discussion.
Research Notes keep observations, questions and correction requests attached to the official-record workflow. This discussion layer is not a recommendation, valuation, legal conclusion or trading venue.
ISSUER COMMUNICATIONS
Open Newsroom Kit →Prepare a source-led update from this record.
Open the Newsroom Kit with this CIK already selected. It creates editable public-record drafts, a source citation and a review handoff—never a published release or a statement of issuer approval.
Company press releases
此区域仅收录公司新闻稿、公司公告或官网发布内容，不重复 SEC 申报动态。当前可先通过 OTC Markets 公司新闻页查看原文。
打开 OTC Markets 新闻原文 ↗Company press releases
公司新闻稿与公告将按公开来源归档；SEC 申报动态继续保留在原有 SEC 模块。
查看新闻稿入口 →Company press releases
Source temporarily unavailable; showing last successful cache · Last updated: 2026/9/20 09:00:08
No press releases cached for this company.
View all press releases →公司业务工具
整理资料与提交需求；公司公告不代表平台项目、在售壳或平台背书。
沿用当前唯一代码；工具内仍需确认公司及业务资料。公司基础资料与来源
Palomino Laboratories Inc. · CIK 0001938569
- 官网
- 未取得未取得：尚未取得适用证据
- 公司简介
- 未取得未取得：尚未取得适用证据
- 行业（来源体系）
- 未取得未取得：尚未取得可归属的SEC SIC；不推定为OTC行业
- 注册州／国家
- 未取得未取得：尚未取得适用证据
- 营业地址所在辖区
- 未取得未取得：尚未取得适用证据
- 国家（统一口径）
- 未取得未取得：未建立注册地、总部或经营地区的统一国家口径
关联证券
- PALX · 证券类型：证券类型待核实
市场分类：未取得
分类属于对应证券；多证券公司不代选主要证券。缺失不表示公司质量较低。
已收录公司动态
暂无已收录动态，不表示公司没有公告。